Sveriges mest populära poddar
The Journal.
NyheterDagliga nyheter

Why WeightWatchers Wants in on Drugs Like Ozempic

17 min•14 mars 2023

WeightWatchers is buying digital health company Sequence to capitalize on the hot market for diabetes and weight loss drugs including Ozempic and Wegovy. WSJ's Andrea Petersen explains what this could mean for the wellness industry.


Further Reading:

-WeightWatchers Moves Into the Ozempic Market With Telehealth Deal 

-How a Diabetes Drug Became the Talk of Hollywood, Tech and the Hamptons 

-Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av The Journal.

Visa alla avsnitt av The Journal.
Let’s Talk Bonds. Treasury Bonds.
•21 min
Why Flock Cameras Are Facing Backlash
•20 min
Why Are Some StubHub Customers So Mad?
•24 min
He's Been a Costco Cashier for 40 Years. Now He's a Millionaire.
•17 min
This Opioid Alternative Is Fueling an Addiction Crisis
•18 min
The Live Auction App Where People Can Bid ‘Til They’re Broke
•27 min
He Thought He Invested in SpaceX. Then His Shares Vanished.
•22 min
To Solve a Cold Case, French Police Bent DNA Privacy Law
•25 min
Jared Kushner's Albania Headache: Flamingos, Contested Land and Cocaine
•22 min
Y Combinator CEO on How AI is Changing What Startups Build
•26 min

The Journal. med The Wall Street Journal & Spotify Studios finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.